4D Molecular Therapeutics logo

4D Molecular Therapeutics

Emeryville, CA

4d Molecular Therapeutics, LLC operates as a biotechnology company. The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions. 4d Molecular Therapeutics serves customers in the State of California.

4dmoleculartherapeutics.com

Company Details

Founded

2013

Employees

227 employees

Raised

$595,000,000

Headquarters Location

Emeryville, CA

Public

Yes

Acquired

No

CEO

David KirnDavid Kirn

Founders

Theresa Janke
Theresa Janke
David Schaffer
David Schaffer
David Kirn
David Kirn

Company Collections

These are collections 4D Molecular Therapeutics is a part of. Click on the collection name to view similar companies.

4D Molecular Therapeutics' Industries

4D Molecular Therapeutics' Tech Stack

Company Collections For 4D Molecular Therapeutics

Current Job Listings

Listing 0 of 18 job openings

    4D Molecular Therapeutics Headquarters Location

    5858 Horton Street #455, Emeryville, CA 94608

    Total Amount Raised: $595,000,000

    4D Molecular Therapeutics Funding Rounds

    • Post Ipo Equity

      $300,000,000

    • Post Ipo Equity

      $120,000,000

    • Series C

      $75,000,000

      Series C Investors

      Viking Global Investors
      Cystic Fibrosis Foundation
      Ridgeback Capital Management
      Amzak Health Investors
      ArrowMark Colorado Holdings
      Casdin Capital
      Perceptive Advisors
      Berkeley Catalyst Fund
      Pfizer Venture Investments
      QUAD Investment Management
      Chiesi Ventures
      Pappas Capital
      BVF Partners
      Mirae Asset
      Longevity Vision Fund
      Octagon Capital Advisors

    • IPO

      Unknown

    • Series B

      $90,000,000

      Series B Investors

      Viking Global Investors
      CureDuchenne Ventures
      Ridgeback Capital Management
      Mirae Asset
      Perceptive Advisors
      ArrowMark Colorado Holdings
      Janus Capital
      Pappas Capital
      Pfizer Venture Investments
      Berkeley Catalyst Fund
      Chiesi Ventures
      BVF Partners

    • Series Unknown

      $3,000,000

      Series Unknown Investors

      Cystic Fibrosis Foundation

    • Series Unknown

      $6,999,995

    Funding info provided by Diffbot.

    4D Molecular Therapeutics Reviews

    0 out of 5 stars

    Based on 0 reviews

    Review data

    Share your thoughts

    Worked here? Share your experience. Help others decide if this company is right for them. Write a review on 4D Molecular Therapeutics.

    Recent reviews